by Ubaka Ogbogu | May 25, 2010
On April 28, 2010, the Board of Appeals and Interference (BPAI) of the U.S. Patent and Trademark Office (USPTO) reversed an earlier decision that upheld the claims of U.S. Patent Number 7,029,913, one of the trio of patents commonly known as WARF or Thomson patents....
by Ubaka Ogbogu | May 6, 2010
The recent resignation of two members of the Board of Directors of Assisted Human Reproduction Canada (AHRC), the federal regulatory agency responsible for implementing the provisions of the Assisted Human Reproduction Act, has once again raised questions regarding...
by Michael Rudnicki | Dec 11, 2009
iPS cells give us an unprecedented opportunity to create patient- and disease-specific cells. Labs around the world have demonstrated that iPS cells can generate disease-specific cells for illnesses such as muscular dystrophy, Parkinson’s and type 1 diabetes, among...
by Lisa Willemse | Jun 12, 2009
In the summer of 2008, SCN supported a workshop in Washington DC that brought a number of science, media and policy experts together to discuss what implications the rapidly changing media landscape has to the public’s access and trust in science journalism. A...
by Stem Cell Network | Apr 17, 2009
A publication arising out of the Lay of the Land workshop, has been published by Nature Reports Stem Cells: (2009) doi:10.1038/stemcells.2009.61. See http://www.nature.com/stemcells/2009/0904/090416/full/stemcells.2009.61.html. The Lay of the Land workshop was the...
Comments